Arteris Grants 477,208 RSUs to 25 New Employees as Inducement Awards
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 16 2026
0mins
Should l Buy AIP?
Source: Globenewswire
- Employee Incentive Plan: Arteris has granted a total of 477,208 restricted stock units (RSUs) to 25 newly hired employees under its 2022 Employee Inducement Incentive Plan, aimed at attracting and retaining talent to enhance its competitiveness in the semiconductor industry.
- Compliance Assurance: The stock grants comply with Nasdaq Listing Rule 5635(c)(4), ensuring transparency and compliance in the company's incentive measures, thereby boosting investor confidence.
- Strategic HR Investment: This stock incentive not only attracts high-quality talent but also enhances employee engagement and motivation, driving the company's technological innovation and market expansion in the AI era.
- Technological Leadership: As a leading provider of semiconductor technology, Arteris is committed to accelerating the creation of high-performance, power-efficient silicon, further solidifying its market leadership in the modern AI era.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AIP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AIP
Wall Street analysts forecast AIP stock price to fall
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 29.750
Low
20.00
Averages
20.50
High
21.00
Current: 29.750
Low
20.00
Averages
20.50
High
21.00
About AIP
Arteris, Inc. is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its System IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. It provides semiconductor interconnect IP and SoC Integration Automation software solutions to serve its target end-markets, including automotive, enterprise computing, consumer electronics, communications across wired and wireless, and industrial markets. Its two core product platforms are Network-on-Chip IP Products and SoC Integration Automation Software Solutions Products. Its Network-on-Chip IP products include Non-coherent NoC IP, with FlexGen, FlexNoC and FlexWay; Cache-coherent NoC IP, with Ncore, and NoC interface IP, with CodaCache. Its SoC Integration Automation Software Solutions products include IP and SoC software, with Magillem (Connectivity and Registers) and CSRCompiler.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Director's Sale: Antonio J Viana, a director at Arteris, sold 20,000 shares on May 5, 2026, for approximately $601,000, indicating a trend of ongoing reductions in executive holdings that could impact market confidence in corporate governance.
- Ownership Structure Change: Following the transaction, Viana holds 20,840 shares directly and 104,620 shares indirectly, totaling 125,460 shares, with a 16.05% reduction in indirect holdings, reflecting a shift in his holding strategy.
- Trading Plan Context: The sale was executed under a Rule 10b5-1 trading plan adopted on June 10, 2025, indicating that this reduction was pre-arranged rather than opportunistic, which may influence investor expectations regarding future transactions.
- Market Reaction and Impact: On the transaction date, AIP's stock price was $30.07, with a market capitalization of $1.47 billion; although this sale did not cause significant price fluctuations, ongoing executive sell-offs may raise concerns about the company's future performance.
See More
- Share Sale Details: On May 5, 2026, the Viana Family Trust sold 20,000 shares of Arteris at approximately $30.07 per share, resulting in a transaction value of about $601,000, which represented 13.75% of their total holdings at that time.
- Holding Changes: Following this sale, the direct holdings of the Viana Family Trust remained unchanged at 20,840 shares, while indirect holdings decreased to 104,620 shares, indicating a trend of ongoing reductions in executive holdings.
- Market Impact: As a leading provider of semiconductor interconnect intellectual property, Arteris's technology is embedded in critical applications across automotive, AI, and communications, and the continuous executive sell-off may negatively affect market confidence.
- Investor Attention: Despite Arteris's competitive edge in the high-growth semiconductor market, analysts noted that the company was not included in The Motley Fool Stock Advisor's recommended stocks, suggesting that investors should exercise caution when considering investments.
See More
- Financial Overview: AIP Realty Trust's press release reveals a fiscal year revenue of $524,000, which, despite showing some growth, is overshadowed by a significant net loss of $4.3 million, indicating challenges in profitability.
- Revenue Source Analysis: The reported revenue of $524,000 has not been sufficient to offset high operational costs, placing the company at a competitive disadvantage and highlighting the urgent need for financial health improvements.
- Loss Causes Investigation: The net loss of $4.3 million is primarily attributed to high management fees and operational expenditures, which exert pressure on investor confidence and could impact future financing capabilities.
- Future Outlook: AIP Realty Trust must implement effective strategies to enhance revenue and control costs to achieve sustainable growth and improve its financial condition, thereby attracting more investor interest in its long-term potential.
See More
- Transaction Overview: Saiyed Atiq Raza, a member of Arteris' Board of Directors, indirectly sold 90,000 shares for approximately $1.99 million across multiple open-market transactions on April 17 and 20, 2026, demonstrating his timing acumen in a rising market.
- Shareholding Changes: Post-transaction, Raza's direct holdings remained at 20,839 shares while indirect holdings decreased to 300,000 shares, indicating that 23.08% of his indirect holdings were sold, suggesting future sales may be smaller due to limited capacity.
- Market Context: The shares were sold at $22.16 each, while Arteris stock has appreciated by 287.5% over the past year, providing Raza with a favorable liquidity window, reflecting strong demand for the company's products in the AI sector.
- Investor Implications: Although Raza's sale raised eyebrows, it was executed under a Rule 10b5-1 trading plan established in November 2025, and with the company experiencing a 22% year-over-year revenue increase to $70.6 million in 2025, investors need not be overly concerned.
See More
- Sale Overview: Arteris Director Saiyed Atiq Raza sold 90,000 shares on April 17 and 20, 2026, for approximately $1.99 million at around $22.16 per share, representing 21.91% of his total pre-transaction holdings.
- Holding Changes: Following the transaction, Raza's direct holdings decreased to 20,839 shares, while indirect holdings remained at 300,000 shares, indicating a strategic adjustment in his ownership structure in response to market dynamics.
- Market Performance Analysis: Over the past year, Arteris's stock price surged by 304.24%, reaching a 52-week high of $27 shortly after Raza's sale, reflecting strong demand driven by advancements in artificial intelligence.
- Transaction Plan Background: The stock sale was executed under a Rule 10b5-1 trading plan established in November 2025, aimed at avoiding insider trading allegations, suggesting that Raza's sale does not indicate a negative outlook on the company's future prospects.
See More
- Stock Performance: Arteris, Inc. shares rose 9.9% to $26.72 in the last trading session, with trading volume significantly above average, indicating strong market confidence in the company's growth prospects.
- Strong Demand: The robust demand for the company's semiconductor design IP solutions, particularly in data centers, automotive, and consumer electronics, has driven the adoption of its FlexGen AI-driven Smart NoC product, which has been licensed for over 30 production deployments.
- Earnings Expectations: Arteris is expected to report a quarterly loss of $0.08 per share in its upcoming earnings report, reflecting an 11.1% year-over-year change, with revenues projected at $21.1 million, up 27.7% from the previous year, showcasing the company's revenue growth potential.
- Market Trends: While the consensus EPS estimate has remained unchanged over the last 30 days, empirical research indicates that trends in earnings estimate revisions are closely correlated with near-term stock price movements, making it crucial for investors to monitor AIP's future performance.
See More











